All patients but one, were classified as APS according to the Sapporo criteria [1], whereas one patient presented with high titer aPL, severe mitral regurgitation (MR) secondary to LSE but without prior APS thrombotic or obstetric-classifying manifestations. The gene discussed is FASLG; the disease is Mitral regurgitation.